Cargando…
Temporal dynamics of immune response following prolonged myocardial ischemia/reperfusion with and without cyclosporine A
Understanding the dynamics of the immune response following late myocardial reperfusion is critical for the development of immunomodulatory therapy for myocardial infarction (MI). Cyclosporine A (CSA) possesses multiple therapeutic applications for MI, but its effects on the inflammation caused by a...
Autores principales: | Rusinkevich, Vitali, Huang, Yin, Chen, Zhong-yan, Qiang, Wu, Wang, Yi-gang, Shi, Yu-fang, Yang, Huang-tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786364/ https://www.ncbi.nlm.nih.gov/pubmed/30858476 http://dx.doi.org/10.1038/s41401-018-0197-1 |
Ejemplares similares
-
Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury
por: Hefler, Joshua, et al.
Publicado: (2022) -
Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats
por: Zhang, Chang-xiong, et al.
Publicado: (2019) -
Protective Effects of Co-Administration of Gallic Acid and Cyclosporine on Rat Myocardial Morphology Against Ischemia/Reperfusion
por: Dianat, Mahin, et al.
Publicado: (2014) -
Cyclosporine-insensitive mode of cell death after prolonged myocardial ischemia: Evidence for sarcolemmal permeabilization as the pivotal step
por: Sciuto, Katie J., et al.
Publicado: (2018) -
Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion
por: Zalewski, Jaroslaw, et al.
Publicado: (2015)